Company / Capital Expenditures
ARDELYX, INC. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$1.5M
FY2025
5-year range
$55.0K / $1.9M
FY2021-FY2025
Trend
+47.6%
vs FY2024
Sector context
#103 of 194
Health Care
What the data says
At $1M, ARDELYX, INC.'s capital expenditures ranks #103 of 194 in the Health Care sector. Capital Expenditures has increased for 3 consecutive years, from $55,000 in FY2022 to $1M in FY2025.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of +35.7%.
Improved from $344,000 to $1M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +200.5%
- 5-Year CAGR
- +35.7%
- 10-Year CAGR
- -
Sector benchmark
#103 of 194 in Health CareTop 53% of 194This company $1.5M Sector average $117.5M
▼
-98.7% below sector average
Key checks
Key Insights
- ARDELYX, INC.'s capital expenditures has grown for 3 consecutive years.
- 5-year CAGR of +35.7%, indicating consistent growth.
- In FY2025, capital expenditures increased 47.6% year-over-year.
- Ranks #103 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.5M | +47.6% |
| FY2024 | $1.0M | +193.9% |
| FY2023 | $344.0K | +525.5% |
| FY2022 | $55.0K | -97.1% |
| FY2021 | $1.9M | +476.2% |
| FY2020 | $324.0K | -0.3% |
| FY2019 | $325.0K | +4.5% |
| FY2018 | $311.0K | -91.0% |
| FY2017 | $3.5M | +86.1% |
| FY2016 | $1.9M | -46.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026